C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 1 filers reported holding C4 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,000 | -76.9% | 71,163 | -65.7% | 0.00% | -50.0% |
| Q2 2023 | $571,000 | -7.8% | 207,456 | +5.3% | 0.00% | -33.3% |
| Q1 2023 | $619,000 | -46.8% | 197,045 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $1,163,000 | -42.8% | 197,045 | -15.1% | 0.01% | -44.4% |
| Q3 2022 | $2,034,000 | +18.5% | 231,966 | +1.9% | 0.01% | +28.6% |
| Q2 2022 | $1,717,000 | +47.5% | 227,725 | +374.6% | 0.01% | +75.0% |
| Q1 2022 | $1,164,000 | -2.6% | 47,985 | +29.3% | 0.00% | 0.0% |
| Q4 2021 | $1,195,000 | -28.0% | 37,122 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,659,000 | +18.1% | 37,122 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $1,405,000 | +2.3% | 37,122 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,373,000 | – | 37,122 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $17,795,000 | 7.09% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $60,745,000 | 3.44% |
| Soleus Capital Management, L.P. | 464,068 | $17,166,000 | 3.09% |
| Cormorant Asset Management, LP | 2,490,065 | $92,107,000 | 2.05% |
| P.A.W. CAPITAL CORP | 50,000 | $1,850,000 | 1.63% |
| Perceptive Advisors | 3,158,566 | $116,835,000 | 1.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 497,136 | $18,389,000 | 1.41% |
| Mizuho Securities Co. Ltd. | 169,392 | $6,266,000 | 1.30% |
| RTW INVESTMENTS, LP | 2,149,228 | $79,437,000 | 1.24% |
| Darwin Global Management, Ltd. | 140,034 | $5,180,000 | 1.01% |